1 Eli Lilly Division That Roared Into 2013 (LLY)

1 Eli Lilly Division That Roared Into 2013

Eli Lilly (NYSE: LLY ) is one of the most prominent drugmakers on the globe. However, with a market cap exceeding $62 billion and product offerings in a wide range of therapeutic areas, it can be difficult for investors to understand every aspect of its business. In this segment, health care analyst Max Macaluso takes a close look at a specific division that generated more than $2 billion in revenue last year but that many Lilly investors might not know about: animal health.

Can Eli Lilly beat the patent cliff?
Over the next two years, Eli Lilly will see nearly $0.40 of every $1.00 in sales exposed to generic competition. How does the company plan to respond to this huge patent cliff? Better yet, what does this mean for investors? In a brand new premium report on Eli Lilly, The Motley Fool's top pharmaceuticals analyst delves into everything investors need to know about the stock today. Simply click here now to claim your copy.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Report this Comment On February 20, 2013, at 10:15 AM, noneofyourbiz wrote:

Nice try at getting personal information. Give us a break. If you have something of value, say it without a registration.The information you provide is usually benign and available without giving up confidentiality.